Evan Barry
Impact in
- Cell Biology top 1%
- Hippo pathway signaling and YAP/TAZ
- Cellular Mechanics and Interactions
- Molecular Biology top 10%
- Wnt/β-catenin signaling in development and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Ubiquitin and proteasome pathways
Papers in
-
- Wnt/β-catenin signaling in development and cancer 3
- Epigenetics and DNA Methylation 2
- Ubiquitin and proteasome pathways 2
- Genomics and Chromatin Dynamics 2
-
- Liver physiology and pathology 4
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Fernando D. Camargo (4 shared papers)Charles S. Fuchs (1 shared paper)Ron Smits (1 shared paper)Kelley S. Yan (1 shared paper)Scott T. Magness (1 shared paper)Rosemarie de la Rosa (1 shared paper)Calvin J. Kuo (1 shared paper)Teppei Morikawa (1 shared paper)
- Journals
- Cancer Research (4 papers)Clinical Cancer Research (2 papers)Oncotarget (2 papers)EMBO Molecular Medicine (1 paper)Stem Cells (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Evan Barry
17 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 75
- Cell Biology 847
- Molecular Biology 857
- Oncology 227
- Cancer Research 81
- Biochemistry 39
Countries citing papers authored by Evan Barry
This map shows the geographic impact of Evan Barry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Barry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Barry more than expected).
Fields of papers citing papers by Evan Barry
This network shows the impact of papers produced by Evan Barry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Barry. The network helps show where Evan Barry may publish in the future.
Co-authors
The 25 scholars most cited alongside Evan Barry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 445 | |
| 2 | 2011 | 393 | |
| 3 | 2013 | 179 | |
| 4 | 2009 | 67 | |
| 5 | 2009 | 63 | |
| 6 | 2015 | 60 | |
| 7 | 2016 | 58 | |
| 8 | 2021 | 52 | |
| 9 | 2010 | 31 | |
| 10 | 2016 | 27 | |
| 11 | 2016 | 23 | |
| 12 | 2020 | 9 | |
| 13 | 2020 | 6 | |
| 14 | 2014 | 6 | |
| 15 | 2015 | 2 | |
| 16 | 2018 | 1 | |
| 17 | 2016 | 1 |
About Evan Barry
Evan Barry is a scholar working on Molecular Biology, Hepatology, Pathology and Forensic Medicine, Cell Biology and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (4 papers), Liver physiology and pathology (4 papers), Hippo pathway signaling and YAP/TAZ (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Epigenetics and DNA Methylation (2 papers), Ubiquitin and proteasome pathways (2 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Cell Biology (847 citations), Molecular Biology (857 citations), Oncology (227 citations), Cancer Research (81 citations) and Biochemistry (39 citations). Evan Barry has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Fernando D. Camargo, Charles S. Fuchs, Ron Smits, Kelley S. Yan, Scott T. Magness, Rosemarie de la Rosa, Calvin J. Kuo, Teppei Morikawa, Kriti Shrestha and Shuji Ogino. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Oncotarget, EMBO Molecular Medicine and Stem Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.